Director, Early Development
Rob joined Molecular Profiles in 2010 and leads the pharmaceutical development services, which integrates preclinical CMC, solid state form optimisation and formulation development for early clinical trials through to the end of Phase II. With a Chemistry degree from the University of London and PhD in Pharmaceutics from University of Manchester, Rob has over 30 years of pharmaceutical industrial experience. Working in GMP environments for both commercial and investigational medicinal products at blue chip and small to medium sized companies, Rob has successfully managed the development of over 50 new chemical entities. Rob also brings extensive expertise in the on-time delivery of clinical trial materials for contract research services.